INSMED INCORPORATED

AEROKAYCE

pharmaceutical preparations for the treatment of lung infections and pulmonary diseases;

AKTIVATE

ACTIVATE;Providing personal support services for patients, namely, assistance with understanding and following treatment plans, coordination with healthcare providers, and advice and information regarding non-clinical treatment questions, disease-specific education, the use and maintenance of medical devices, and the administration and use of pharmaceutical preparations, all of the foregoing for the treatment of lung infections and pulmonary diseases;Providing medical case management services, namely, in the nature of assisting patients undergoing treatment for lung infections or pulmonary diseases with understanding and following treatment plans and coordinating with healthcare providers; providing advice and information to patients undergoing treatment for lung infections or pulmonary diseases regarding non-clinical treatment questions, disease-specific education, and the use and maintenance of medical devices; providing treatment consultation, namely, consulting with patients regarding administration and use of pharmaceutical preparations for lung infections and pulmonary diseases;

APMYN

Pharmaceutical preparations for the treatment of sarcoidosis, interstitial lung disease, pulmonary fibrosis, and idiopathic pulmonary fibrosis; Pharmaceutical preparations for the treatment of pulmonary hypertension, pulmonary arterial hypertension (PAH), pulmonary hypertension associated with lung disease, pulmonary hypertension associated with interstitial lung disease (PH-ILD), pulmonary hypertension associated with chronic obstructive pulmonary disease, portopulmonary hypertension, pulmonary hypertension associated with sleep-related breathing disorders, pulmonary hypertension associated with chronic thrombotic and embolic disease, and pulmonary hypertension secondary to hematologic, metabolic, renal, granulomatous, or fibrotic disorders;

ARIKACE

Pharmaceutical preparations for the treatment of lung infections;

ARIKARE

Personal support services for patients undergoing treatment of lung infections and pulmonary diseases, namely, providing assistance with understanding and following treatment plans, coordination with healthcare providers, disease-specific education and the use and maintenance of medical devices;Medical services, namely, providing medical advice to patients regarding administration and use of pharmaceutical preparations for the treatment of lung infections and pulmonary diseases;

ARIKARES

Personal support services for patients undergoing treatment of lung infections and pulmonary diseases, namely, providing assistance with understanding and following treatment plans, coordination with healthcare providers, disease-specific education and the use and maintenance of medical devices;Medical services, namely, providing medical advice to patients regarding administration and use of pharmaceutical preparations for the treatment of lung infections and pulmonary diseases;

CHAPULMI

Pharmaceutical preparations for the treatment of sarcoidosis, interstitial lung disease, pulmonary fibrosis, and idiopathic pulmonary fibrosis; Pharmaceutical preparations for the treatment of pulmonary hypertension, pulmonary arterial hypertension (PAH), pulmonary hypertension associated with lung disease, pulmonary hypertension associated with interstitial lung disease (PH-ILD), pulmonary hypertension associated with chronic obstructive pulmonary disease, portopulmonary hypertension, pulmonary hypertension associated with sleep-related breathing disorders, pulmonary hypertension associated with chronic thrombotic and embolic disease, and pulmonary hypertension secondary to hematologic, metabolic, renal, granulomatous, or fibrotic disorders;

DEIMMUNIZED BY DESIGN

Computational design and molecular engineering of therapeutic proteins for medical use;

DICHAMA

Pharmaceutical preparations for the treatment of sarcoidosis, interstitial lung disease, pulmonary fibrosis, and idiopathic pulmonary fibrosis; Pharmaceutical preparations for the treatment of pulmonary hypertension, pulmonary arterial hypertension (PAH), pulmonary hypertension associated with lung disease, pulmonary hypertension associated with interstitial lung disease (PH-ILD), pulmonary hypertension associated with chronic obstructive pulmonary disease, portopulmonary hypertension, pulmonary hypertension associated with sleep-related breathing disorders, pulmonary hypertension associated with chronic thrombotic and embolic disease, and pulmonary hypertension secondary to hematologic, metabolic, renal, granulomatous, or fibrotic disorders;

ENGINEERING IMMUNOTOLERANCE

Computational design and molecular engineering of therapeutic proteins for medical use;

ENSODEPPI

Pharmaceutical preparations for the treatment and prevention of neutrophil-mediated diseases and conditions; pharmaceutical preparations for the treatment and prevention of lung diseases and conditions; pharmaceutical preparations for the treatment and prevention of pulmonary diseases and conditions; pharmaceutical preparations for the treatment and prevention of rhinitis; pharmaceutical preparations for the treatment and prevention of behcet disease; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of metastasis; pharmaceutical preparations for the treatment and prevention of rheumatoid arthritis; pharmaceutical preparations for the treatment and prevention of inflammatory bowel disease; pharmaceutical preparations for the treatment and prevention of kidney diseases and conditions;

IN STRIDE

Personal support services for patients undergoing treatment of lung infections and pulmonary diseases, namely, providing assistance with understanding and following treatment plans, coordination with healthcare providers, disease-specific education and the use and maintenance of medical devices;Medical services, namely, providing medical advice to patients regarding administration and use of pharmaceutical preparations for the treatment of lung infections and pulmonary diseases;

INSMED

pharmaceutical preparations for the treatment of pulmonary diseases;

INSMED

Pharmaceutical preparations for the treatment of rare pulmonary and rare neuromuscular diseases; pharmaceutical preparations for the treatment of orphan pulmonary and orphan neuromuscular diseases; pharmaceutical preparations for the treatment of genetic disorders and diseases;

INSMED

Pharmaceutical preparations for the treatment of inflammatory diseases; Pharmaceutical preparations for the treatment of muscular disorders; Pharmaceutical preparations for the treatment of neuromuscular disorders;

INSMED

Pharmaceutical preparations for the treatment of cardiac muscle disorders and diseases; Pharmaceutical preparations for the treatment of skeletal muscle disorders and diseases;

INSTRIDE

IN STRIDE;Personal support services for patients undergoing treatment of lung infections and pulmonary diseases, namely, providing assistance with understanding and following treatment plans, coordination with healthcare providers, disease-specific education and the use and maintenance of medical devices;Medical services, namely, providing medical advice to patients regarding administration and use of pharmaceutical preparations for the treatment of lung infections and pulmonary diseases;

KAYSPIRIS

pharmaceutical preparations for the treatment of lung infections and pulmonary diseases;

LONSPIRA

pharmaceutical preparations for the treatment of respiratory diseases and disorders;

NCFBE DIALOGUE

Educational services, namely, conducting seminars, non-downloadable webinars, conferences, programs and lectures in the field of science; conducting educational conferences in the field of medical science; educational services, namely, conducting seminars in the field of medicine; educational services, namely, conducting classes and online instruction in the field of therapeutic treatments; arranging and conducting of conferences and congresses in the fields of medicine and pharmaceuticals for educational purposes;The mark consists of a stylized image of lungs that appears to the right of the wording NCFBE in uppercase and DIALOGUE in uppercase underneath.;Color is not claimed as a feature of the mark.;NCFBE DIALOGUE;

NTM

Publication of printed matter of the results of clinical trials for pharmaceutical preparations; publication of leaflets; publication of printed matter and printed publications in the nature of leaflets, brochures, manuals; publication of educational materials in the nature of manuals, journals, books; publishing of medical publications in the nature of manuals, journals, books; written text editing for publication; organizing of educational exhibitions in the field of science; organization of educational events in the nature of seminars, conferences, workshops, programs and lectures in the field of science; conducting of educational events in the nature of seminars, conferences, workshops, programs and lectures in the field of science; medical training and teaching; publishing scientific papers in relation to medical technology; organization of conferences in the field of medical science for educational purposes; organizing of educational seminars in the field of science; planning of seminars for educational purposes; conducting of educational seminars relating to medical matters; education services, namely, providing classes and instructions relating to therapeutic treatments; arranging and conducting of conferences, congresses, courses, in particular in the fields of medicine and pharmaceuticals for educational purposes;Retail store services featuring pharmaceutical preparations; advertising relating to pharmaceutical products; advertising services to promote public awareness of medical diseases and infections; marketing services in the nature of developing marketing campaigns; developing promotional campaigns for businesses; business consultancy services relating to management of fund raising campaigns; business consultancy services relating to the marketing of fund raising campaigns; business consultancy services relating to the promotion of fund raising campaigns; organization of exhibitions and events for commercial or advertising purposes; compilation of business statistical data relating to medical research for business purposes; provision of business statistical information relating to medical matters; collection of data and management of data for business purposes in connection with clinical research, testing, trial and development of pharmaceuticals, therapeutics and medical devices;

NTM ACTION

Educational services, namely, providing online education, instruction and training in the field of the diagnosis, symptoms, treatment and impact of respiratory diseases, including non-tuberculous mycobacterium pulmonary disease, via an online website; providing on-line non-downloadable newsletters, educational materials, and articles in the field of the diagnosis, symptoms, treatment and impact of respiratory diseases, including non-tuberculous mycobacterium pulmonary disease;The mark consists of a stylized image of lungs that appears to the left of the stacked terms NTM in uppercase and action in lowercase.;Color is not claimed as a feature of the mark.;Providing a website featuring information in the field of the diagnosis, symptoms, treatment and impact of respiratory diseases, including non-tuberculous mycobacterium pulmonary disease;NTM;

NTM DIALOGUE

Organization of educational events in the nature of seminars, conferences, programs and lectures in the field of science; conducting of educational events in the nature of seminars, conferences, programs and lectures in the field of science; organization of conferences in the field of medical science for educational purposes; organizing of educational seminars in the field of science; conducting of educational seminars relating to medical matters; education services, namely, providing classes and instructions relating to therapeutic treatments; arranging and conducting of conferences and congresses, in particular in the fields of medicine and pharmaceuticals for educational purposes;The mark consists of NTM DIALOGUE and a stylized lungs design.;Color is not claimed as a feature of the mark.;Organization of exhibitions and events for commercial or advertising purposes;NTM AND DIALOGUE FOR INTERNATIONAL CLASS 41;

OCHAPSIS

Pharmaceutical preparations for the treatment of sarcoidosis, interstitial lung disease, pulmonary fibrosis, and idiopathic pulmonary fibrosis; Pharmaceutical preparations for the treatment of pulmonary hypertension, pulmonary arterial hypertension (PAH), pulmonary hypertension associated with lung disease, pulmonary hypertension associated with interstitial lung disease (PH-ILD), pulmonary hypertension associated with chronic obstructive pulmonary disease, portopulmonary hypertension, pulmonary hypertension associated with sleep-related breathing disorders, pulmonary hypertension associated with chronic thrombotic and embolic disease, and pulmonary hypertension secondary to hematologic, metabolic, renal, granulomatous, or fibrotic disorders;

PULMOVANCE

providing medical and health information via a global computer network;

PULMOVANCE

medical devices, namely, nebulizers;

PULMOVANT

pharmaceutical preparations for the treatment of lung infections and pulmonary diseases;providing medical and health information via a global computer network;medical devices, namely, nebulizers;

S

The mark consists of a series of rectangles arranged in two ribbons to form an S.;STEALTH;Color is not claimed as a feature of the mark.;Computational design and molecular engineering of therapeutic proteins for medical use;